Literature DB >> 16775313

Immunogenicity of cytopathic and noncytopathic viral vectors.

Gabriela Plesa1, Philip M McKenna, Matthias J Schnell, Laurence C Eisenlohr.   

Abstract

The impact of cytolytic versus noncytolytic viral infections on host responses is not well understood, due to limitations of the systems that have been used to address this issue. Using paired cytopathic and noncytopathic rabies viruses that differ by only two amino acids, we investigated several fundamental aspects of the immune response to these viral vectors. Greater cytopathic capacity translated into a greater degree of cross-priming to CD8(+) T cells (T(CD8)(+)) and more-robust short-term humoral and cellular responses. However, long-term responses to the two viruses were similar, suggesting that direct priming drives the bulk of the T(CD8)(+) antirabies response and that enhanced acute responses associated with greater virally mediated cellular destruction were balanced by other factors, such as prolonged antigen expression associated with noncytopathic virus. Such compensatory mechanisms may be in place to ensure comparable immunologic memories to various pathogens.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16775313      PMCID: PMC1488949          DOI: 10.1128/JVI.00084-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  61 in total

Review 1.  Viruses and interferon: a fight for supremacy.

Authors:  Michael G Katze; Yupeng He; Michael Gale
Journal:  Nat Rev Immunol       Date:  2002-09       Impact factor: 53.106

Review 2.  On cross-priming of MHC class I-specific CTL: rule or exception?

Authors:  Rolf M Zinkernagel
Journal:  Eur J Immunol       Date:  2002-09       Impact factor: 5.532

3.  High avidity CD8+ T cells are the initial population elicited following viral infection of the respiratory tract.

Authors:  Peter M Gray; Griffith D Parks; Martha A Alexander-Miller
Journal:  J Immunol       Date:  2003-01-01       Impact factor: 5.422

4.  Cross-priming of CD8+ T cells by viral and tumor antigens is a robust phenomenon.

Authors:  Weisan Chen; Kelly-Anne Masterman; Sameh Basta; S M Mansour Haeryfar; Nektaria Dimopoulos; Barbara Knowles; Jack R Bennink; Jonathan W Yewdell
Journal:  Eur J Immunol       Date:  2004-01       Impact factor: 5.532

5.  Second-generation rabies virus-based vaccine vectors expressing human immunodeficiency virus type 1 gag have greatly reduced pathogenicity but are highly immunogenic.

Authors:  James P McGettigan; Roger J Pomerantz; Catherine A Siler; Philip M McKenna; Heather D Foley; B Dietzschold; Matthias J Schnell
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

6.  Contrasting effects of matrix protein on apoptosis in HeLa and BHK cells infected with vesicular stomatitis virus are due to inhibition of host gene expression.

Authors:  Sarah A Kopecky; Douglas S Lyles
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

7.  Dendritic cells cross-present HIV antigens from live as well as apoptotic infected CD4+ T lymphocytes.

Authors:  Concepción Marañón; Jean-François Desoutter; Guillaume Hoeffel; William Cohen; Daniel Hanau; Anne Hosmalin
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-12       Impact factor: 11.205

8.  Dendritic cells transfected with cytopathic self-replicating RNA induce crosspriming of CD8+ T cells and antiviral immunity.

Authors:  Vito Racanelli; Sven Erik Behrens; Julio Aliberti; Barbara Rehermann
Journal:  Immunity       Date:  2004-01       Impact factor: 31.745

Review 9.  Transcriptional control of the RNA-dependent RNA polymerase of vesicular stomatitis virus.

Authors:  John N Barr; Sean P J Whelan; Gail W Wertz
Journal:  Biochim Biophys Acta       Date:  2002-09-13

10.  Requirement of caspase-3 for efficient apoptosis induction and caspase-7 activation but not viral replication or cell rounding in cells infected with vesicular stomatitis virus.

Authors:  Jacqueline A Hobbs; Grace Hommel-Berrey; Zacharie Brahmi
Journal:  Hum Immunol       Date:  2003-01       Impact factor: 2.850

View more
  6 in total

1.  Identification and Characterization of a Small-Molecule Rabies Virus Entry Inhibitor.

Authors:  Venice Du Pont; Christoph Wirblich; Jeong-Joong Yoon; Robert M Cox; Matthias J Schnell; Richard K Plemper
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

Review 2.  Designing CD8+ T cell vaccines: it's not rocket science (yet).

Authors:  Jonathan W Yewdell
Journal:  Curr Opin Immunol       Date:  2010-05-04       Impact factor: 7.486

3.  A role for granulocyte-macrophage colony-stimulating factor in the regulation of CD8(+) T cell responses to rabies virus.

Authors:  Celestine N Wanjalla; Elizabeth F Goldstein; Christoph Wirblich; Matthias J Schnell
Journal:  Virology       Date:  2012-02-16       Impact factor: 3.616

4.  Guanylyl cyclase C-induced immunotherapeutic responses opposing tumor metastases without autoimmunity.

Authors:  Adam E Snook; Benjamin J Stafford; Peng Li; Gene Tan; Lan Huang; Ruth Birbe; Stephanie Schulz; Matthias J Schnell; Mathew Thakur; Jay L Rothstein; Laurence C Eisenlohr; Scott A Waldman
Journal:  J Natl Cancer Inst       Date:  2008-06-24       Impact factor: 13.506

5.  A Quasi-Steady-State Approximation to the Basic Target-Cell-Limited Viral Dynamics Model with a Non-Cytopathic Effect.

Authors:  Richard A Cangelosi; Elissa J Schwartz; David J Wollkind
Journal:  Front Microbiol       Date:  2018-01-31       Impact factor: 5.640

6.  A novel composite immunotoxin that suppresses rabies virus production by the infected cells.

Authors:  Tatiana Mareeva; Celestine Wanjalla; Matthias J Schnell; Yuri Sykulev
Journal:  J Immunol Methods       Date:  2009-11-22       Impact factor: 2.287

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.